A retrospective study on the efficacy of a ten-milligram dosage of atorvastatin for treatment of hypercholesterolemia in type 2 diabetes mellitus patients.
BACKGROUND
There have been few clinical studies on 10 mg atorvastatin as a starting dosage for treatment of hypercholesterolemia in type 2 diabetes mellitus (T2DM) patients. This retrospective study aims to evaluate the efficacy of 10 mg dosage of atorvastatin in clinical setting.


METHODS
One hundred five enrolled patients with high levels of low density lipoprotein cholesterol (LDL-C, > 100 mg/dL) took 10 mg atorvastatin. After 6 months, they were divided into 'Responder group' (LDL-C < 100 mg/dL) and 'Non-responder group' (LDL-C ≥ 100 mg/dL), and the response rate was calculated. Thereafter, we subdivided the 'Responder group' into Maintenance (10 mg), Reduced dosage (5 mg), and Discontinuance group (0 mg). The 'Non-Responder group' was subdivided into Maintenance (10 mg) and Double dosage group (20 mg). After consecutive 6 months, the response rates of each 10 mg Maintenance groups were compared to those of the other groups, respectively.


RESULTS
Following the first 6 months, the response rate of 10 mg fixed dosage was 74.3%. In the 'Responder group', response rates of 10 mg, 5 mg and Discontinuance groups following 6 months were 52.6%, 53.1%, and 12.5%, respectively. In the 'Non-responder group', response rates of 10 mg and 20 mg groups were 28.6% and 50.0%. Baseline LDL-C levels and body mass index (BMI) of 'Responder group' were significantly lower than those of 'Non-responder group' (P = 0.004, respectively).


CONCLUSIONS
Hypercholesterolemia treatment with 10 mg, fixed dosage of atorvastatin was effective in three quarters of the subjects during the first 6-month treatment; however, a significant number of patients with high LDL-C levels and/or BMI require higher starting and maintenance dosage.
Department of Internal Medicine, Dong-A University Medical Center, Dong-A University College of Medicine, Busan, Korea.
Dong Kyun
DK
Kim
Sa Rah
SR
Lee
Min Sik
MS
Kim
Suk Hyang
SH
Bae
Jin Yeon
JY
Hwang
Jung-Min
JM
Kim
Sung Hwan
SH
Suh
Hye-Jeong
HJ
Lee
Mi Kyoung
MK
Park
Duk Kyu
DK
Kim
Clin Pharmacol Ther. 2005 Oct;78(4):330-41
16198652
Circulation. 2004 Jul 13;110(2):227-39
15249516
Curr Diab Rep. 2010 Jun;10(3):173-5
20425579
Circulation. 1994 Mar;89(3):1333-445
8124825
Korean J Intern Med. 2008 Mar;23(1):22-9
18363276
N Engl J Med. 2003 Jan 30;348(5):383-93
12556541
Atherosclerosis. 2000 Oct;152(2):489-96
10998478
N Engl J Med. 1995 Nov 16;333(20):1301-7
7566020
J Indian Med Assoc. 2009 Nov;107(11):807-9
20469785
Am J Cardiol. 2007 Feb 1;99(3):410-4
17261409
Diabetes Care. 1993 Feb;16(2):434-44
8432214
JAMA. 2001 May 16;285(19):2486-97
11368702
Stroke. 2003 Dec;34(12):2812-6
14657546